Stem cell transplantation across major genetic barriers

Annals of the New York Academy of Sciences

Volumn 938, Issue , 2001, Pages 322-327

  Reisner, Yair ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Bone marrow engraftment; Graft versus host disease; Veto cells

Indexed keywords

CD8 ANTIGEN; FAS LIGAND;

ALLOGENIC BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0034936398     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03600.x     Document Type: Conference Paper

References (31)

1. + stem cells: A new option for leukemia patients without an HLA-matched donor
2. Tolerance induction by "megadose" hematopoietic transplants: Donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture
3. Cells in bone marrow and in T cell colonies grown from bone marrow can suppress generation of cytotoxic T lymphocytes directed against their self antigens
4. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice
5. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning
6. Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by Sca-1(+)Lin(-) bone marrow progenitor cells: Synergism with non-alloreactive (host x donor)F(1) T cells
7. + thymocytes
8. Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity
9. Enhancement of BM allografting from C57BL/6 "nude" mice into C3H/HeJ recipients by tolerized T cells from (C57BL/6→C3H/HeJ) and (C3H/HeJ→C57BL/6) chimeras
10. Attenuation of graft-versus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination
11. Induction of T cell anergy by low numbers of agonist ligands
12. Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: A method to ameliorate graft-versus-host disease and extend the donor pool
13. Blockade of multiple costimulatory receptors induces hyporesponsiveness: Inhibition of CD2 plus CD28 pathways
14. Veto-like down regulation of T helper cell reactivity in vivo by injection of semi-allogeneic spleen cells
15. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong anti-self suppressive activity
16. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them
17. Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes
18. Veto cells
19. Antiself suppressive (veto) activity of responder cells in mixed lymphocyte cultures
20. Regulation of the cytotoxic T lymphocyte response against Qa-1 alloantigens
21. + cells in the induction of peripheral tolerance
22. Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC
23. Veto cell H-2 antigens: Veto cell activity is restricted by determinants encoded by K, D, and I MHC regions
24. + cells whose class I MHC can bind the peptide
25. Murine and human non-alloreaactive anti-3rd party CTL: A novel facilitating cell with markedly reduced GVH reactivity
26. Hybrid antibody mediated veto of cytotoxic T lymphocyte responses
27. Immunoregulatory role of CD8a in the veto effect. Transforming growth factor-β1 activation
28. An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow
29. Antiretroviral cytolytic T-lymphocyte nonresponsiveness: FasL/Fas-mediated inhibition of CD4(+) and CD8(+) antiviral T cells by viral antigen-positive veto cells
30. Anti-third party CDS+ CTLs as potent veto cells: Coexpression of CD8 and FasL is a prerequisite
31. Inhibition of death receptor signals by cellular FLIP